Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing aprotinin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aprotinin adverse reaction |
Causative agent (attribute) |
True |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to aprotinin (finding) |
Causative agent (attribute) |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aprotinin [pancreatitis] [see chapter b] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trasylol injection 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trasylol injection 10mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aprotinin injection 5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aprotinin injection 10mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aprotinin [fibrinolytic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aprotinin 500,000units/50mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aprotinin injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trasylol injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aprotinin 10,000kiu/mL injection solution 200mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aprotinin 10,000kiu/mL injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to aprotinin (finding) |
Causative agent (attribute) |
True |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aprotinin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aprotinin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aprotinin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aprotinin 1.4 mg/mL solution for injection |
Has precise active ingredient |
True |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aprotinin 1.4 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aprotinin therapy |
Direct substance |
True |
Aprotinin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |